DR info

Clinical trials : 5 / Drugs : 7 - (DrugBank : 4) / Drug target genes : 2 - Drug target pathways : 10

Myelomeningocele and other diseases between which drug repositioning (DR) might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Score (Drug repositionability)

ID	Diseases (Sorted by score)	Score
118	Myelomeningocele	-
6	Parkinson disease	8.000
169	Menkes disease	6.806
170	Occipital horn syndrome	6.806
22	Moyamoya disease	6.344
11	Myasthenia gravis	6.261
206	Fragile X syndrome	6.238
113	Muscular dystrophy	6.229
17	Multiple system atrophy	6.225
5	Progressive supranuclear palsy	6.219
70	Spinal stenosis	6.218
96	Crohn disease	6.161
2	Amyotrophic lateral sclerosis	6.161
46	Malignant rheumatoid arthritis	6.158
280	Huge arteriovenous malformation with cervicofacial or limb lesion	5.143
288	Autoimmune acquired coagulation factor deficiency	5.000
8	Huntington disease	4.607
13	Multiple sclerosis/Neuromyelitis optica	3.160
323	Aromatic L-amino acid decarboxylase deficiency	3.000
57	Idiopathic dilated cardiomyopathy	2.889
215	Tetralogy of Fallot	2.444
210	Single Ventricle	2.250
127	Frontotemporal lobar degeneration	2.200
226	Interstitial cystitis with Hunners ulcer	2.125
85	Idiopathic interstitial pneumonia	2.081
86	Pulmonary arterial hypertension	2.080
212	Tricuspid atresia	1.828
4	Primary lateral sclerosis	1.421
254	Porphyria	1.421
67	Polycystic kidney disease	1.273
78	Hypopituitarism	1.253
21	Mitochondrial disease	1.245
58	Hypertrophic cardiomyopathy	1.242
90	Retinitis pigmentosa	1.240
107	Juvenile idiopathic arthritis	1.233
28	Systemic amyloidosis	1.210
34	Neurofibromatosis	1.190
65	Primary immunodeficiency	1.188
111	Congenital myopathy	1.000